BIOMAT Database Logo BIOMAT Database Logo

Regulation of liver lipid metabolism in experimental obesity [proceedings]. 1977

B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash

UI MeSH Term Description Entries
D007033 Hypothalamus, Middle Middle portion of the hypothalamus containing the arcuate, dorsomedial, ventromedial nuclei, the TUBER CINEREUM and the PITUITARY GLAND. Hypothalamus, Medial,Intermediate Hypothalamic Region,Hypothalamic Region, Intermediate,Hypothalamic Regions, Intermediate,Intermediate Hypothalamic Regions,Medial Hypothalamus,Middle Hypothalamus,Region, Intermediate Hypothalamic,Regions, Intermediate Hypothalamic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Proceedings: Mechanism of lipid metabolism regulation in lipid micelles].
February 1974, Nihon Naibunpi Gakkai zasshi,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Control of lipid metabolism in experimental obesity].
March 1982, Revue canadienne de biologie experimentale,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Lipid metabolism in experimental rat liver lesions].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Physiopathology of lipid metabolism and liver changes in obesity].
January 1995, La Clinica terapeutica,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Problems of metabolism regulation in the liver. 3. Regulation mechanisms in lipid metabolism].
January 1968, Acta hepato-splenologica,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
Regulation of adipose-tissue lipid metabolism in obese-hyperglycaemic mice [proceedings].
January 1977, Biochemical Society transactions,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
Proceedings: Alteration of lipid metabolism subsequent to experimental head injury.
October 1974, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
Insulin regulation of glucose and lipid metabolism in massive obesity.
April 1990, Diabetologia,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
Lipocalin 13 regulation of glucose and lipid metabolism in obesity.
January 2013, Vitamins and hormones,
B Jeanrenaud, and P Freychet, and F Assimacopoulos-Jeannet, and Y le Marchand, and C Karakash
[Liver damage and lipid metabolism. 3. Lipid metabolism in experimental hepatitis of the rat].
January 1971, Acta hepato-splenologica,
Copied contents to your clipboard!